The Cancer Letter

June

Vol.

No.

June 02, 2023

Robert Winn tells us how he led VCU Massey to obtain Comprehensive designation

TABLE OF CONTENTS

May

Vol.

No.

May 26, 2023

Cisplatin, carboplatin shortage prompts rationing of lifesaving drugs—patients will die

TABLE OF CONTENTS

Vol.

No.

May 19, 2023

NIH accused of being late and half-hearted in responding to House investigation of sexual misconduct policies

TABLE OF CONTENTS

Vol.

No.

May 12, 2023

Start breast cancer screening at 40, but screen every two years, USPSTF says. Will America listen?

TABLE OF CONTENTS

Vol.

No.

May 05, 2023

ODAC says prostate cancer patients who lack proven BRCA mutation shouldn’t get PARP inhibitor

TABLE OF CONTENTS

April

Vol.

No.

April 28, 2023

With funds from Ralph Lauren, Georgetown Lombardi opens center for cancer prevention focused on health disparities

TABLE OF CONTENTS

Vol.

No.

April 21, 2023

After 7 months at NCI, Bertagnolli is about to be named NIH director

TABLE OF CONTENTS

Vol.

No.

April 14, 2023

Monica Bertagnolli’s Cancer Plan makes the most of her two roles: NCI director and leader of the National Cancer Program

TABLE OF CONTENTS

Vol.

No.

April 07, 2023

Gary Schwartz talks about his vision for Case CCC, leaving New York, his illustrious father—and Isaac Asimov

TABLE OF CONTENTS

March

Vol.

No.

March 31, 2023

Texas federal judge invalidates ACA preventive care mandate—USPSTF, cancer screening, and PrEP in jeopardy

TABLE OF CONTENTS

Vol.

No.

March 24, 2023

ACT for NIH publishes Mary Lasker biography to use in lobbying for appropriations—Mary would’ve approved

TABLE OF CONTENTS

Vol.

No.

March 17, 2023

Biotech companies, investors pour billions into mRNA vaccines as research ramps up in cancer and non-communicable diseases

TABLE OF CONTENTS

Vol.

No.

March 10, 2023

UNM’s Sanchez: To provide cancer care to Native American, Hispanic communities, you must first establish trust

TABLE OF CONTENTS

Vol.

No.

March 03, 2023

Money, science, and enthusiasm make tails wag in canine comparative oncology

TABLE OF CONTENTS

February

Vol.

No.

February 24, 2023

Ukraine’s year of war has produced a generation of women oncologists trained in the West

TABLE OF CONTENTS

Vol.

No.

February 17, 2023

MSK’s Vickers: “We’ve been seen as exclusive and selected. I want to broaden that aperture for the organization.”

TABLE OF CONTENTS

Vol.

No.

February 10, 2023

ODAC gives thumbs-up to GSK plan to build on MSK rectal cancer study of dostarlimab that produced 100% response

TABLE OF CONTENTS

Vol.

No.

February 03, 2023

Otis Brawley & Robert Winn discuss the killing of Tyre Nichols and the power dynamics in policing—and health care

TABLE OF CONTENTS

January

Vol.

No.

January 27, 2023

Epigeneticists may be looking for epigenome-disease associations in the wrong place

TABLE OF CONTENTS

Vol.

No.

January 20, 2023

ODAC Confidential: The seven deadly sins sponsors commit again and again at FDA presentations

TABLE OF CONTENTS

Vol.

No.

January 13, 2023

Jedd Wolchok: Weill Cornell’s path to NCI designation runs through Brooklyn and Queens

TABLE OF CONTENTS

Vol.

No.

January 06, 2023

What Ruben Mesa is thinking as he steps into one of the most-watched jobs in cancer

TABLE OF CONTENTS

The Cancer Letter

June

Robert Winn tells us how he led VCU Massey to obtain Comprehensive designation

May

Cisplatin, carboplatin shortage prompts rationing of lifesaving drugs—patients will die

NIH accused of being late and half-hearted in responding to House investigation of sexual misconduct policies

Start breast cancer screening at 40, but screen every two years, USPSTF says. Will America listen?

ODAC says prostate cancer patients who lack proven BRCA mutation shouldn’t get PARP inhibitor

April

With funds from Ralph Lauren, Georgetown Lombardi opens center for cancer prevention focused on health disparities

After 7 months at NCI, Bertagnolli is about to be named NIH director

Monica Bertagnolli’s Cancer Plan makes the most of her two roles: NCI director and leader of the National Cancer Program

Gary Schwartz talks about his vision for Case CCC, leaving New York, his illustrious father—and Isaac Asimov

March

Texas federal judge invalidates ACA preventive care mandate—USPSTF, cancer screening, and PrEP in jeopardy

ACT for NIH publishes Mary Lasker biography to use in lobbying for appropriations—Mary would’ve approved

Biotech companies, investors pour billions into mRNA vaccines as research ramps up in cancer and non-communicable diseases

UNM’s Sanchez: To provide cancer care to Native American, Hispanic communities, you must first establish trust

Money, science, and enthusiasm make tails wag in canine comparative oncology

February

Ukraine’s year of war has produced a generation of women oncologists trained in the West

MSK’s Vickers: “We’ve been seen as exclusive and selected. I want to broaden that aperture for the organization.”

ODAC gives thumbs-up to GSK plan to build on MSK rectal cancer study of dostarlimab that produced 100% response

Otis Brawley & Robert Winn discuss the killing of Tyre Nichols and the power dynamics in policing—and health care

January

Epigeneticists may be looking for epigenome-disease associations in the wrong place

ODAC Confidential: The seven deadly sins sponsors commit again and again at FDA presentations

Jedd Wolchok: Weill Cornell’s path to NCI designation runs through Brooklyn and Queens

What Ruben Mesa is thinking as he steps into one of the most-watched jobs in cancer

Renew today!

Subscriber content

Login